Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001070615 | SCV001235876 | benign | Gorlin syndrome | 2024-08-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002320349 | SCV002610626 | likely benign | Hereditary cancer-predisposing syndrome | 2020-03-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Genomic Medicine, |
RCV005232112 | SCV005872528 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing |